Spleen size and platelet count now predict clot risk.

King Faisal Specialist Hospital researchers built the 2-variable score after finding thrombosis in 24 of 83 blood-cancer patients, sidestepping molecular tests most regional hospitals cannot run.

International risk models are validated on European cohorts; this unedited manuscript is one of few built on Middle Eastern patients.

Sources: Nature